Filter

201 - 210 of 363 Results

  • The Court’s Opening Shot on Federal Vaccine Policy Changes

    Quick Insights

    A growing number of states, reaching 30 as of March, have announced that they are no longer following CDC recommendations as their benchmark for some or all childhood vaccines... The court’s stay does not change these states’ decisions and in some ways may allow them to avoid a potential ‘ping pong’ of federal vaccine policy that could result from future legal rulings or actions by the administration.

  • Analysis Finds The Share of Nursing Home Staff Who Have Been Vaccinated Against COVID-19 Varies Substantially by State

    News Release

    The share of nursing home staffers who have been fully vaccinated against COVID-19 varies considerably by state, from 70 percent in Ohio to 99 percent in Maine, Rhode Island, New York and Massachusetts, a new KFF analysis finds. The national average is 84 percent. The analysis of federal nursing home data for the week ending Jan. 30 comes as providers strive to comply with a federal mandate that health care workers whose employers participate in…

  • KFF COVID-19 Vaccine Monitor: February 2022

    Poll Finding

    Two years into the COVID-19 pandemic, the public is split on their readiness to return to normal, with many worried about the consequences of lifting restrictions and of not lifting them. At this point, the pandemic is not a top issue for voters in November's midterm elections . Most parents are not confident in the safety of the vaccine for kids under 5.

  • The COVAX Humanitarian Buffer for COVID-19 Vaccines: Review and Assessment of Policy Implications

    Issue Brief

    In this Issue Brief we review and assess the COVAX Humanitarian Buffer mechanism, which is part of the effort to share Covid vaccines globally. The Buffer is intended to direct vaccines to vulnerable people like refugees and others facing humanitarian emergencies during the pandemic, and was supported by the US and many other donors and organizations. However, it faced many challenges such as liability and indemnification issues for using newly developed vaccines, restricted access to…

  • Monkeypox (MPX) Cases and Vaccinations by Race/Ethnicity

    Issue Brief

    A small number of states, as well as some local jurisdictions, are reporting race/ethnicity data on MPX cases and vaccinations and these data show a disproportionate impact of MPX cases on Black and Hispanic people. The data available to date on vaccinations also suggest that Black and Hispanic people are receiving smaller shares of vaccinations despite accounting for larger shares of cases.